Stock Information
  Corporate Presentation
  Financial News
  Earnings Estimate
  Media Kit
  Analyst Coverage
  Financial Reports
  SEC Filings
  Event Calendar
  FAQs
  E-mail Alerts
  Information Request







(NASDAQ DRRX) 0.78   +0.01

  Stock Information
  Corporate Presentation
  Financial News
  Earnings Estimate
  Media Kit
  Analyst Coverage
  Financial Reports
  SEC Filings
  Event Calendar
  FAQs
  E-mail Alerts
  Information Request


The Company currently has several late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas.



DURECT Corporation is a specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas.

... 
More >>
Featured Report
Download Documentation DURECT 2010 Letter to the Shareholders
DRRX (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Price$0.78
Change (%) Stock is Up 0.01 (1.30%)
Volume445,153
Data as of 02/03/12 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
01/30/12DURECT Receives Back European Product Rights to POSIDUR™Printer Friendly Version
01/05/12DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)Printer Friendly Version
11/07/11DURECT Corporation to Participate in Upcoming Healthcare ConferencesPrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever DURECT Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 
Transfer Agent
Computershare Trust Company N.A.
250 Royall Street, Mailstop 3B
Canton, MA 02021
Phone: 781- 575-3400

Accountants
Ernst & Young LLP
1001 Page Mill Road
Palo Alto, CA 94304
Phone: 650-496-1600
Fax: 650-496-1600

Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.





© 2000-2011 DURECT Corporation
Last updated: September 20, 2011
Search    Contact    Site Index    Legal Notice    Privacy Policy  


 
 © 2000-2012 DURECT Corporation
Last updated: January 30, 2012
Search     Contact     Site Index     Legal Notice     Privacy Policy